This work aimed to evaluate the use of optical coherence tomography (OCT) to guide the drug-eluting stent implantation during primary angioplasty. 201 patients experiencing STEMI to use or not OCT during primary angioplasty were randomized. The clinical and angiographic characteristics were well balanced, and no differences in MACE, cardiac death, TLR, or stent thrombosis at 30 days or 9 months between the two groups were observed.
Conclusion
The OCT to guide primary angioplasty in STEMI is safe but does not provide additional benefits in terms of clinical or angiographic end points.
P. Cervinka
2014-05-20
Title: OCT guidance during stent implantation in primary PCI: a randomised multicentre study with 9-month angiographic follow-up.
